1. Multidrug resistance protein 4 is a critical protein associated with the antiviral efficacy of nucleos(t)ide analogues
   Wei Liu et al, 2016, Liver International CrossRef
2. Characterization of Chrysin Glucuronidation in UGT1A1-Overexpressing HeLa Cells: Elucidating the Transporters Responsible for Efflux of Glucuronide
   Enxi Quan et al, 2015, Drug Metabolism and Disposition CrossRef
3. Cyclic AMP efflux inhibitors as potential therapeutic agents for leukemia
   Dominique R. Perez et al, 2016, Oncotarget CrossRef
4. Histamine H2 Receptor in Blood Cells: A Suitable Target for the Treatment of Acute Myeloid Leukemia
   Federico Monczor et al, 2016, Histamine and Histamine Receptors in Health and Disease CrossRef
5. Ganciclovir and Its Hemocompatible More Lipophilic Derivative Can Enhance the Apoptotic Effects of Methotrexate by Inhibiting Breast Cancer Resistance Protein (BCRP)
   Magdalena Markowicz-Piasecka et al, 2021, International Journal of Molecular Sciences CrossRef
6. Current Progress for the Use of miRNAs in Glioblastoma Treatment
   Amanda Tivnan et al, 2013, Molecular Neurobiology CrossRef
7. Acyclovir Brain Disposition: Interactions with P-gp, Bcrp, Mrp2, and Oat3 at the Blood–Brain Barrier
   Yuheng Shan et al, 2022, European Journal of Drug Metabolism and Pharmacokinetics CrossRef
8. Absorption, Distribution, Metabolism, and Excretion of the Novel Helicase-Primase Inhibitor, Amenamevir (ASP2151), in Rodents
   Yoshiaki Ohtsu et al, 2018, European Journal of Drug Metabolism and Pharmacokinetics CrossRef